Nilotinib
-
Molecular Structure
Detailed Description
Nilotinib is a Bcr-Abl inhibitor with IC50 less than 30 nM. It is under investigation as a possible treatment for chronic myelogenous leukemia (CML).
https://www.bocsci.com/nilotinib-cas-641571-10-0-item-84-74229.html
- Nilotinib